Institutional investors hold a majority ownership of BMY through the 71.81% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2017, these large investors purchased a net $626.0 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 7.0 Million shares of Bristol-Myers Squibb
PRIMECAP MANAGEMENT CO. Bought 4.5 Million shares of Bristol-Myers Squibb
FRANKLIN ADVISERS, INC. Bought 3.9 Million shares of Bristol-Myers Squibb